Canaccord Genuity
Canaccord Genuity is the global capital markets division of Canaccord Financial Inc. (CF : TSX | CF. : AIM), offering institutional and corporate clients idea-driven investment banking, research, sales and trading services.
The companies has operations in 24 cities worldwide and the ability to list companies on 10 stock exchanges.
-
Canaccord Genuity Reiterates Buy Rating on TransMedics Group (TMDX)
-
TransMedics Group (TMDX) PT Lowered to $104 at Canaccord Genuity
-
TransMedics Group (TMDX) PT Lowered to $109 at Canaccord Genuity
-
Canaccord Genuity Reiterates Buy Rating on TransMedics Group (TMDX)
-
TransMedics Group (TMDX) PT Raised to $169 at Canaccord Genuity
-
TransMedics to Present at the Canaccord Genuity 44th Annual Growth Conference
-
TransMedics Group (TMDX) PT Raised to $117 at Canaccord Genuity
-
TRANSMEDICS ALERT: Bragar Eagel & Squire, P.C. is Investigating TransMedics Group, Inc. on Behalf of TransMedics Stockholders and Encourages Investors to Contact the Firm
-
Bridge to Life Divests Certain Assets to TransMedics
-
TransMedics Group (TMDX) Acquires Warm Perfusion EVOSS and Cold Perfusion LifeCradle Technologies from Bridge to Life
-
TransMedics Acquires Warm Perfusion EVOSS™ and Cold Perfusion LifeCradle® Technologies from Bridge to Life
-
TransMedics to Present at the Canaccord Genuity 43rd Annual Growth Conference
-
TransMedics Group (TMDX) Prices Upsized 3.25M Share Offering at $40/sh
-
TransMedics Announces Upsize and Pricing of Public Offering of Common Stock
-
TransMedics Group (TMDX) Announces Proposed $100M Stock Offering
-
TransMedics Announces Proposed Public Offering of Common Stock
-
TransMedics to Present at the Canaccord Genuity 42nd Annual Growth Conference
-
TransMedics Group (TMDX) PT Raised to $39 at Canaccord Genuity Following Virtual NDR
-
TransMedics to Participate in the Canaccord Genuity Virtual MedTech, Diagnostics, and Digital Health & Services Forum
-
TransMedics Group (TMDX) KOL Call Takeaways - Canaccord Genuity
-
TransMedics Group (TMDX) OCS Heart DBD Receives Broader Than Expected Label- Canaccord Genuity
-
TransMedics to Participate in the Canaccord Genuity 41st Annual Growth Conference
-
TransMedics Group (TMDX) PT Raised to $79 at Canaccord Genuity Ahead of a Transformational Year
-
TransMedics to Participate in Upcoming Virtual Investor Conferences
-
UPDATE: TransMedics Group (TMDX) Prices 5M Share Common Offering at $14/Sh
-
TransMedics Announces Pricing of Public Offering of Common Stock
-
TransMedics Announces Pricing of Public Offering of Common Stock
-
TransMedics Group (TMDX) Announces Proposed $60M Public Offering of Common Stock
-
TransMedics Announces Proposed Public Offering of Common Stock
-
TransMedics Announces Proposed Public Offering of Common Stock
-
TransMedics Group (TMDX) PT Lowered to $25 at Canaccord Genuity
-
TransMedics to Present at the 39th Annual Canaccord Genuity Global Growth Conference
-
TransMedics to Present at the 39th Annual Canaccord Genuity Global Growth Conference
-
Canaccord Genuity Starts TransMedics Group (TMDX) at Buy
-
TransMedics Announces Closing of its Initial Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares
-
TransMedics Announces Closing of its Initial Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares
-
TransMedics (TMDX) IPO Opens 27% Higher

